Multiple Myeloma — Trials, FDA Actions & Pivotal Research
13 updates aggregated from openFDA and ClinicalTrials.gov, covering trial milestones, FDA actions, and pivotal publications about Multiple Myeloma.
Synced daily from openFDA and ClinicalTrials.gov. Last sync: .
Drugs with Multiple Myeloma trials
Recruiting trials by city
Cities where Multiple Myeloma trials in our archive had recruiting sites. Each link lists every currently recruiting paid clinical trial at that location.
Updates
2026
- Results postedMultiple Myeloma: COVID-19 Outcomes Trial Posts Data Capture Feasibility· May 18, 2026
- Primary completionElranatamab Phase 3 Trial for Multiple Myeloma Reaches Primary Completion· Apr 27, 2026· drug: Elranatamab
- Primary completionTalquetamab Phase 3 Trial for Multiple Myeloma Reaches Primary Completion· Apr 23, 2026· drug: Talquetamab
- Results postedElranatamab Multiple Myeloma Combination Trial Terminated, DLTs Reported· Feb 23, 2026· drug: Elranatamab
- Results postedLeukemia Patients: Hospice Model Reduces Acute Care, Chemotherapy· Jan 15, 2026
2025
- Results postedMultiple Myeloma: Health Through Activity Pilot Study Posts Results· Dec 16, 2025
- Results postedMultiple Myeloma: Scalp Cooling Reduces Hair Loss in Stem Cell Transplant…· Oct 27, 2025
- Results postedLymphoma Pain Management Intervention Trial Posts Feasibility Results· Sep 18, 2025
- Results postedMultiple Myeloma Imaging Protocol Results Posted, Quantifying Tumor Burden· Aug 19, 2025
- Results postedHIV & Immunocompromised Patients: ImmunoCARE Trial Shows Reduced Care Costs· Aug 8, 2025
- Results postedMyoStrain® Trial Results Posted: Detecting Cardiotoxicity in Breast Cancer· Jul 29, 2025
- Results postedNivolumab: Safety Data Posted for Myeloma, Lymphoma Trial· Jul 25, 2025· drug: Nivolumab
- Results postedElranatamab Shows Improved Progression-Free Survival in Multiple Myeloma· Jun 27, 2025· drug: Elranatamab